Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 165

1.

Regulation of ULK1 Expression and Autophagy by STAT1.

Goldberg AA, Nkengfac B, Sanchez AM, Moroz N, Qureshi ST, Koromilas AE, Wang S, Burelle Y, Hussain SN, Kristof AS.

J Biol Chem. 2017 Feb 3;292(5):1899-1909. doi: 10.1074/jbc.M116.771584.

PMID:
28011640
2.

Insulin resistance of protein anabolism accompanies that of glucose metabolism in lean, glucose-tolerant offspring of persons with type 2 diabetes.

Burgos SA, Chandurkar V, Tsoukas MA, Chevalier S, Morais JA, Lamarche M, Marliss EB.

BMJ Open Diabetes Res Care. 2016 Nov 29;4(1):e000312.

3.

Mathematical Model of Bone Remodeling Captures the Antiresorptive and Anabolic Actions of Various Therapies.

Ross DS, Mehta K, Cabal A.

Bull Math Biol. 2017 Jan;79(1):117-142. doi: 10.1007/s11538-016-0229-2.

PMID:
27905067
4.

One year of abaloparatide, a selective peptide activator of the PTH1 receptor, increased bone mass and strength in ovariectomized rats.

Varela A, Chouinard L, Lesage E, Guldberg R, Smith SY, Kostenuik PJ, Hattersley G.

Bone. 2017 Feb;95:143-150. doi: 10.1016/j.bone.2016.11.027.

PMID:
27894941
5.

Wnt signaling and cellular metabolism in osteoblasts.

Karner CM, Long F.

Cell Mol Life Sci. 2016 Nov 26. [Epub ahead of print] Review.

PMID:
27888287
6.

One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption.

Varela A, Chouinard L, Lesage E, Smith SY, Hattersley G.

J Bone Miner Res. 2017 Jan;32(1):24-33. doi: 10.1002/jbmr.3003.

PMID:
27748532
7.

Hyperinsulinemic-normoglycemic clamp administered together with amino acids induces anabolism after cardiac surgery.

Codère-Maruyama T, Schricker T, Shum-Tim D, Wykes L, Nitschmann E, Guichon C, Kristof AS, Hatzakorzian R.

Am J Physiol Regul Integr Comp Physiol. 2016 Dec 1;311(6):R1085-R1092. doi: 10.1152/ajpregu.00334.2016.

PMID:
27707724
8.

Discovery of novel dihydrobenzofuran cyclopropane carboxylic acid based calcium sensing receptor antagonists for the treatment of osteoporosis.

Liang GB, Zhou C, Huo X, Wang H, Yang X, Huang S, Wang H, Wilkinson H, Luo L, Tang W, Sutton D, Li H, Zaller D, Meinke PT.

Bioorg Med Chem Lett. 2016 Aug 15;26(16):4077-80. doi: 10.1016/j.bmcl.2016.06.073.

PMID:
27397499
9.

Enhanced Wnt signaling improves bone mass and strength, but not brittleness, in the Col1a1(+/mov13) mouse model of type I Osteogenesis Imperfecta.

Jacobsen CM, Schwartz MA, Roberts HJ, Lim KE, Spevak L, Boskey AL, Zurakowski D, Robling AG, Warman ML.

Bone. 2016 Sep;90:127-32. doi: 10.1016/j.bone.2016.06.005.

PMID:
27297606
10.

Rictor/mTORC2 loss in osteoblasts impairs bone mass and strength.

Liu DM, Zhao L, Liu TT, Jiao PL, Zhao DD, Shih MS, Tao B, Sun LH, Zhao HY, Liu JM.

Bone. 2016 Sep;90:50-8. doi: 10.1016/j.bone.2016.05.010.

PMID:
27262777
11.

The use of gas chromatography-mass spectrometry/combustion/isotope ratio mass spectrometry to demonstrate progesterone treatment in bovines.

Janssens G, Mangelinckx S, Courtheyn D, De Kimpe N, Matthijs B, Le Bizec B.

J Chromatogr A. 2016 Jun 3;1449:129-40. doi: 10.1016/j.chroma.2016.04.074.

PMID:
27157423
12.

Corrigendum to "Analysis of anabolic steroids in urine by gas chromatography-microchip atmospheric pressure photoionization-mass spectrometry with chlorobenzene as dopant" [J. Chromatogr. A 1312 (2013) 111-117].

Hintikka L, Haapala M, Kuuranne T, Leinonen A, Kostiainen R.

J Chromatogr A. 2016 May 27;1448:128. doi: 10.1016/j.chroma.2016.04.059. No abstract available.

PMID:
27133863
13.
14.

Pharmacological inhibition of cathepsin K: A promising novel approach for postmenopausal osteoporosis therapy.

Mukherjee K, Chattopadhyay N.

Biochem Pharmacol. 2016 Oct 1;117:10-9. doi: 10.1016/j.bcp.2016.04.010. Review.

PMID:
27106079
15.

Discovering Biology in Periodic Data through Phase Set Enrichment Analysis (PSEA).

Zhang R, Podtelezhnikov AA, Hogenesch JB, Anafi RC.

J Biol Rhythms. 2016 Jun;31(3):244-57. doi: 10.1177/0748730416631895.

PMID:
26955841
16.

5,6-Dehydrokawain from Alpinia zerumbet promotes osteoblastic MC3T3-E1 cell differentiation.

Kumagai M, Mishima T, Watanabe A, Harada T, Yoshida I, Fujita K, Watai M, Tawata S, Nishikawa K, Morimoto Y.

Biosci Biotechnol Biochem. 2016 Jul;80(7):1425-32. doi: 10.1080/09168451.2016.1153959.

PMID:
26940726
17.

Does Teriparatide Improve Femoral Neck Fracture Healing: Results From A Randomized Placebo-controlled Trial.

Bhandari M, Jin L, See K, Burge R, Gilchrist N, Witvrouw R, Krohn KD, Warner MR, Ahmad QI, Mitlak B.

Clin Orthop Relat Res. 2016 May;474(5):1234-44. doi: 10.1007/s11999-015-4669-z.

PMID:
26932738
18.

Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis Study.

Dempster DW, Zhou H, Recker RR, Brown JP, Recknor CP, Lewiecki EM, Miller PD, Rao SD, Kendler DL, Lindsay R, Krege JH, Alam J, Taylor KA, Janos B, Ruff VA.

J Clin Endocrinol Metab. 2016 Apr;101(4):1353-63. doi: 10.1210/jc.2015-4181.

19.

Effect of anti-sclerostin therapy and osteogenesis imperfecta on tissue-level properties in growing and adult mice while controlling for tissue age.

Sinder BP, Lloyd WR, Salemi JD, Marini JC, Caird MS, Morris MD, Kozloff KM.

Bone. 2016 Mar;84:222-9. doi: 10.1016/j.bone.2016.01.001.

PMID:
26769006
20.

Annual banned-substance review: analytical approaches in human sports drug testing.

Thevis M, Kuuranne T, Walpurgis K, Geyer H, Schänzer W.

Drug Test Anal. 2016 Jan;8(1):7-29. doi: 10.1002/dta.1928. Review.

PMID:
26767774
Items per page

Supplemental Content

Loading ...
Support Center